The protective effects of lafutidine for bortezomib induced peripheral neuropathy

Peripheral neuropathy (PN) caused by bortezomib is an important complication of multiple myeloma. Subcutaneous injection of bortezomib reduced PN, but 24% of cases were grade 2 PN and 6% of cases were grade 3 PN. PN higher than grade 2 was not resolved by subcutaneous injection. PN higher than grade...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsukaguchi, Machiko, Shibano, Masaru, Matsuura, Ai, Mukai, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712744/
https://www.ncbi.nlm.nih.gov/pubmed/23874126
http://dx.doi.org/10.2147/JBM.S44127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712744/
https://www.ncbi.nlm.nih.gov/pubmed/23874126
http://dx.doi.org/10.2147/JBM.S44127

Ejemplares similares